CRESCO LABS INC by Cresco Labs Inc. Analyst Price Targets - Benzinga

CRESCO LABS INC by Cresco Labs Inc.

CRLBFOTCQX

Trade with Public

Trade with Public

$0.6167

0.01672.78%

Últ. Act.: Oct 26, 3:59 PM

Panorámica general Noticias Previsión de beneficiosPrecios objetivoFinanzas Sentimiento Comparar

© 2026 Benzinga | All Rights Reserved

CRESCO LABS INC by Cresco Labs Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for CRESCO LABS INC by Cresco Labs Inc. (CRLBF).

Price Target Range — 2 Quarters

Analyst Consensus — 4 Analysts

2Buy

2Hold

Consensus RatingNeutral# Analysts4Avg. Consensus PT$3Upside to Avg. PT+305.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 12, 2024	Needham	Matt McGinley	Maintained	Hold	—
Jun 12, 2024	Zuanic & Associates	Pablo Zuanic	Initiate	Overweight	—
May 16, 2024	Needham	Matt McGinley	Maintained	Hold	—
May 16, 2024	Wedbush	Gerald Pascarelli	PT Raise	Outperform	$3→$3
Mar 14, 2024	Roth MKM	Scott Fortune	PT Raise	Neutral	$2→$2

Analyst Ratings News

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government bonds.

Nicolás Jose Rodriguez

80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?

According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.

Nicolás Jose Rodriguez

Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning

The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration.

Nicolás Jose Rodriguez

M&A Frenzy And Deflation Post-Election: Which Companies Are Ready To Win Big In Florida's Cannabis Market

November's election could bring significant growth opportunities—or intensified competition for cannabis companies in the Florida market.

Nicolás Jose Rodriguez

Can MariMed's $7.7M Illinois Cannabis Expansion Turn The Tide In A $496M Market?

Despite overall market stagnation, MariMed aims to boost growth through capacity expansion, including a new 14,000 sq ft cultivation site.

Nicolás Jose Rodriguez

Why Cannabis Investors Should Make This Bold Move Before Florida's Vote: What To Buy And Sell Now

AYR's exposure to Florida gives it an edge ahead of potential recreational cannabis legalization, per Viridian Capital.

Nicolás Jose Rodriguez